Wei T - Search Results

1

Vincristine upregulates PD-L1 and increases the efficacy of PD-L1 blockade therapy in diffuse large B-cell lymphoma.

Wei T, Li M, Zhu Z, Xiong H, Shen H, Zhang H, Du Q, Li Q. Wei T, et al. J Cancer Res Clin Oncol. 2021 Mar;147(3):691-701. doi: 10.1007/s00432-020-03446-w. Epub 2021 Jan 2. J Cancer Res Clin Oncol. 2021. PMID: 33389078

2

Role of heterogeneous regulatory T cells in the tumor microenvironment.

Wei T, Zhong W, Li Q. Wei T, et al. Pharmacol Res. 2020 Mar;153:104659. doi: 10.1016/j.phrs.2020.104659. Epub 2020 Jan 23. Pharmacol Res. 2020. PMID: 31982490 Review.

3

GBP1 promotes erlotinib resistance via PGK1‑activated EMT signaling in non‑small cell lung cancer.

Cheng L, Gou L, Wei T, Zhang J. Cheng L, et al. Among authors: wei t. Int J Oncol. 2020 Sep;57(3):858-870. doi: 10.3892/ijo.2020.5086. Epub 2020 Jun 22. Int J Oncol. 2020. PMID: 32582960

4

Comparison of gene mutation spectra in younger and older Chinese acute myeloid leukemia patients and its prognostic value.

Zhong WJ, Liu XD, Zhong LY, Li KB, Sun QX, Xu X, Wei T, Li QS, Zhu ZG. Zhong WJ, et al. Among authors: wei t. Gene. 2021 Feb 20;770:145344. doi: 10.1016/j.gene.2020.145344. Epub 2020 Dec 14. Gene. 2021. PMID: 33333221 Clinical Trial.

5

Down-regulation of cylindromatosis protein phosphorylation by BTK inhibitor promotes apoptosis of non-GCB-diffuse large B-cell lymphoma.

Xu X, Wei T, Zhong W, Ang R, Lei Y, Zhang H, Li Q. Xu X, et al. Among authors: wei t. Cancer Cell Int. 2021 Apr 7;21(1):195. doi: 10.1186/s12935-021-01891-2. Cancer Cell Int. 2021. PMID: 33827598 Free PMC article.

6

Inhibition of N-acetylglucosaminyltransferase V enhances sensitivity of radiotherapy in human prostate cancer.

Huang H, Chen W, Liu Q, Wei T, Zhu W, Meng H, Guo L, Zhang J. Huang H, et al. Among authors: wei t. Biochem Biophys Res Commun. 2014 Aug 29;451(3):345-51. doi: 10.1016/j.bbrc.2014.06.097. Epub 2014 Aug 10. Biochem Biophys Res Commun. 2014. PMID: 25117443

7

Long non-coding RNA TUG1 is involved in cell growth and chemoresistance of small cell lung cancer by regulating LIMK2b via EZH2.

Niu Y, Ma F, Huang W, Fang S, Li M, Wei T, Guo L. Niu Y, et al. Among authors: wei t. Mol Cancer. 2017 Jan 9;16(1):5. doi: 10.1186/s12943-016-0575-6. Mol Cancer. 2017. PMID: 28069000 Free PMC article.

8

Role of the dynamic tumor microenvironment in controversies regarding immune checkpoint inhibitors for the treatment of non-small cell lung cancer (NSCLC) with EGFR mutations.

Lin A, Wei T, Meng H, Luo P, Zhang J. Lin A, et al. Among authors: wei t. Mol Cancer. 2019 Sep 16;18(1):139. doi: 10.1186/s12943-019-1062-7. Mol Cancer. 2019. PMID: 31526368 Free PMC article. Review.

9

SR9009 induces a REV-ERB dependent anti-small-cell lung cancer effect through inhibition of autophagy.

Shen W, Zhang W, Ye W, Wang H, Zhang Q, Shen J, Hong Q, Li X, Wen G, Wei T, Zhang J. Shen W, et al. Among authors: wei t. Theranostics. 2020 Mar 15;10(10):4466-4480. doi: 10.7150/thno.42478. eCollection 2020. Theranostics. 2020. PMID: 32292508 Free PMC article.

10

High mutations in fatty acid metabolism contribute to a better prognosis of small-cell lung cancer patients treated with chemotherapy.

Lyu Q, Zhu W, Wei T, Ding W, Cao M, Wang Q, Guo L, Luo P, Zhang J. Lyu Q, et al. Among authors: wei t. Cancer Med. 2021 Nov;10(21):7863-7876. doi: 10.1002/cam4.4290. Epub 2021 Sep 26. Cancer Med. 2021. PMID: 34564955 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3,945 results

Search Page

Filters